Oflo G 400mg Tablet
strip of 10.0 tablets.Prescription required
About this product:
| Salt Composition: | Ofloxacin (400mg) |
| Manufacturer: | Vrinda Life |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Oflo G 400mg Tablet is an antibiotic that helps treat bacterial infections, such as urinary tract, nose, throat, skin and soft tissues, and lungs (pneumonia) infections. Oflo G 400mg Tablet is an antibiotic that helps treat bacterial infections. It is used in treating infections of the urinary tract, nose, throat, skin and soft tissues, and lungs (pneumonia). It cures the infection by stopping the further growth of the causative bacteria.
Oflo G 400mg Tablet is an antibiotic. It works by stopping the action of a bacterial enzyme called DNA-gyrase. This prevents the bacterial cells from dividing and repairing, thereby killing them.
What potential gastrointestinal side effects may occur with Oflo G 400mg Tablet?
Diarrhea is a possible side effect of Oflo G 400mg Tablet, as the antibiotic can disrupt the balance of good bacteria in the stomach or intestine. If severe diarrhea persists, consult your doctor for guidance.
What should I do if my symptoms improve while taking Oflo G 400mg Tablet?
It is essential to complete the full course of treatment with Oflo G 400mg Tablet, even if your symptoms seem to have improved. Stopping the medication too soon can leave you vulnerable to incomplete eradication of the infection.
Can Oflo G 400mg Tablet increase my risk of muscle damage?
Yes, taking Oflo G 400mg Tablet may elevate your risk of developing muscle damage, particularly in the Achilles tendon. If you experience any muscle pain or discomfort while using this medication, inform your doctor promptly.
Your doctor has prescribed Oflo G 400mg Tablet to cure your infection and improve symptoms.
- No common side effects listed.
Breastfeed
Inform your doctor if you are breastfeeding.
Pregnancy
Inform your doctor if you are pregnant or planning to conceive.
